Concentration of Risk

PFIZER INC

Medium

PFE · NYSE · Pharmaceutical Preparations · CIK 0000078003

Latest filing: 10-K · 2026-02-26

Customer concentration

Significant Customers note · revenue dependency

Medium
Top exposure
25%
McKesson, Inc.
Other major customers
Cencora, Inc.16%
Cardinal Health, Inc.13%
Each is a separate customer disclosed individually — the figures are not sub-parts of the headline and may be measured against different revenue bases, so they are not additive.
+2.0pp YoY

Click a point to open the SEC source

FY23FY24FY250%7%14%21%28%

Geographic concentration

Segment reporting · geographic revenue

Low
Top exposure
<10%
No disclosure detected
Flat

Supplier concentration

Risk Factors · supply chain dependency

Low
Dependency
Diversified
Diversified
Flat

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

High
Top exposure
65%
12 products
Products disclosed
12 products65%
Eliquis13%
Flat

Click a point to open the SEC source

FY250%20%40%60%80%

Credit concentration

ASC 825 · concentration of credit risk note

Low
Receivables
<10%
Diversified
Flat